Medicxi is a European investment firm specializing in life sciences, with a focus on drug discovery and the development of therapeutics addressing unmet medical needs. Founded in 2016 by the former Index Ventures life sciences team, the firm builds on decades of sector experience and continues to manage the legacy Index Ventures life sciences portfolio.